Orchid Pharma Limited (NSE:ORCHPHARMA)
688.40
-16.70 (-2.37%)
At close: Jan 23, 2026
Orchid Pharma Employees
Orchid Pharma had 736 employees as of March 31, 2025. The number of employees decreased by 135 or -15.50% compared to the previous year.
Employees
736
Change (1Y)
-135
Growth (1Y)
-15.50%
Revenue / Employee
11.16M INR
Profits / Employee
712.02K INR
Market Cap
34.92B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 736 | -135 | -15.50% |
| Mar 31, 2024 | 871 | 33 | 3.94% |
| Mar 31, 2023 | 838 | -108 | -11.42% |
| Mar 31, 2022 | 946 | -190 | -16.73% |
| Mar 31, 2021 | 1,136 | -142 | -11.11% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Akums Drugs and Pharmaceuticals | 7,536 |
| Indoco Remedies | 6,000 |
| Strides Pharma Science | 3,301 |
| Alivus Life Sciences | 2,203 |
| Aarti Pharmalabs | 2,162 |
| Solara Active Pharma Sciences | 1,775 |
| Innova Captab | 1,600 |
| Windlas Biotech | 1,346 |
Orchid Pharma News
- 2 months ago - Orchid Pharma Ltd (BOM:524372) Q2 2026 Earnings Call Highlights: Strategic Acquisitions and ... - GuruFocus
- 2 months ago - Q2 2026 Orchid Pharma Ltd Earnings Call Transcript - GuruFocus
- 6 months ago - Top stocks to buy today: Stock recommendations for July 16, 2025 - check list - The Times of India
- 8 months ago - Orchid Pharma shares drop nearly 5% as Q4 net profit falls 32.4% YoY to Rs 22.3 crore - Business Upturn
- 1 year ago - Orchid Pharma shares surge 4.4% after successful USFDA inspection at Alathur API facility - Business Upturn
- 1 year ago - Orchid Pharma successfully completes USFDA inspection at Alathur API facility, secures EU GMP certification renewal - Business Upturn
- 1 year ago - Orchid Pharma shares drop over 14% as net profit falls 25.63% YoY to ₹22.45 crore in Q3 - Business Upturn
- 1 year ago - Orchid Pharma shares jump nearly 4% following strong Q2 FY25 results - Business Upturn